ES2059453T3 - Un procedimiento para la produccion de interleuquina 4 humana. - Google Patents

Un procedimiento para la produccion de interleuquina 4 humana.

Info

Publication number
ES2059453T3
ES2059453T3 ES88112458T ES88112458T ES2059453T3 ES 2059453 T3 ES2059453 T3 ES 2059453T3 ES 88112458 T ES88112458 T ES 88112458T ES 88112458 T ES88112458 T ES 88112458T ES 2059453 T3 ES2059453 T3 ES 2059453T3
Authority
ES
Spain
Prior art keywords
human
human interleukin
dna sequence
located below
promoter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88112458T
Other languages
English (en)
Inventor
Tasuku Honjo
Kazuaki Hama
Akiyoshi Kawasaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2059453T3 publication Critical patent/ES2059453T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00—Other engines
    • F02B75/02—Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA NUEVA INTERLEUCINA 4 (IL4) HUMANA CON EFECTOS INMUNOACTIVANTES QUE SE CARACTERIZA POR (A) UN PESO MOLECULAR TOTAL DE 17000 A 19000, (B) UN PESO MULECULAR DE LA CADENA DE AZUCAR DE 2000 A 4000; Y TAMBIEN DESCRIBE NUEVOS VECTORES DE EXPRESION PARA LA IL4 HUMANA, QUE COMPRENDEN: (1) UNA SECUENCIA DE DNA CODIFICANDO LA INTERLEUCINA 4 HUMANA SITUADA POR DEBAJO DE UN PROMOTOR INICIAL DE SV40, Y (2) UNA SECUENCIA DE DNA CODIFICADORA DE LA DIHIDROFALATO REDUCTORA SITUADA POR DEBAJO DE UN PROMOTOR QUE ACTUA EN CELULAS EUCARIANTES, ADEMAS DESCRIBE LOS TRANSFORMANTES OBTENIDOS POR MEDIO DE LA INYECCION DE EL VECTOR DE EXPRESION DE LA IL4 HUMANA EN CELULAS DE OVARIO DE HAMSTER CHINO DIHIDROFOLATO - REDUCTORA DEFECTIVAS. LA IL4 HUMANA ES UTIL PARA EL TRATAMIENTO Y PREVENCION DE CANCER, INFECCIONES, SIDA, DEFICIENCIAS INMUNOLOGICAS FUNCIONALES, ETC.
ES88112458T 1987-08-03 1988-08-01 Un procedimiento para la produccion de interleuquina 4 humana. Expired - Lifetime ES2059453T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19266687 1987-08-03
JP3948288 1988-02-24

Publications (1)

Publication Number Publication Date
ES2059453T3 true ES2059453T3 (es) 1994-11-16

Family

ID=26378886

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88112458T Expired - Lifetime ES2059453T3 (es) 1987-08-03 1988-08-01 Un procedimiento para la produccion de interleuquina 4 humana.

Country Status (4)

Country Link
EP (1) EP0302429B1 (es)
KR (1) KR890003804A (es)
DE (1) DE3882611T2 (es)
ES (1) ES2059453T3 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2218420B (en) * 1988-04-12 1992-07-15 British Bio Technology Synthetic gene encoding interleukin 4
ZA912037B (en) * 1990-03-21 1992-03-25 Schering Corp Use of il-4 to enhance immune response to infectious antigenic challenges
US5206345A (en) * 1990-08-02 1993-04-27 Fred Hutchinson Cancer Research Center Il-4 and tnf induce mab 6g10-recognized expression on bone marrow stromal cells
US7449186B1 (en) 1990-08-02 2008-11-11 Fred Hutchinson Cancer Research Center Methods of blocking the interaction between stromal cells and hemopoietic cells with anti-VCAM-1 antibodies
US5827670A (en) * 1990-08-02 1998-10-27 Fred Hutchinson Cancer Research Center Methods of isolating and detecting bone marrow stromal cells with VCAM-1-specific antibodies
DK0552243T3 (da) * 1990-09-06 1997-03-10 Schering Corp Anvendelse af interleukin-4 til behandling af faste tumorer
DK0566661T3 (da) * 1991-01-10 1996-07-01 Schering Corp Anvendelse af IL-4 til forstærkning af den reparative fase af sårheling og -reparation og til forstærkning af helingen af inficerede sår og sår hos diabetiske pattedyr
US5494662A (en) * 1992-04-27 1996-02-27 Ono Pharmaceutical Co., Ltd. Stimulator for bone formation
US7361331B2 (en) 1996-10-18 2008-04-22 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food Plant bioreactors
EP1141338A4 (en) 1998-12-31 2002-09-25 Arch Dev Corp RECOMBINANT HERPES SIMPLEX VIRUS FOR TREATING NEOPLASTIC DISEASES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT83761B (pt) * 1985-11-19 1989-06-30 Schering Biotech Corp Metodo para a producao de interleuquina-4 de mamifero
ZA872781B (en) * 1986-05-19 1987-10-05 Immunology Ventures B-cell stimulating factor

Also Published As

Publication number Publication date
EP0302429A1 (en) 1989-02-08
DE3882611D1 (de) 1993-09-02
DE3882611T2 (de) 1993-12-23
EP0302429B1 (en) 1993-07-28
KR890003804A (ko) 1989-04-18

Similar Documents

Publication Publication Date Title
ES2059453T3 (es) Un procedimiento para la produccion de interleuquina 4 humana.
Trotter et al. Differentiation‐regulated loss of the polysialylated embryonic form and expression of the different polypeptides of the neural cell adhesion molecule by cultured oligodendrocytes and myelin
BR8305812A (pt) Combinacao, composicao de borracha vulcanizavel com enxofr e processo para formacao de um artigo
ES2173082T3 (es) Vectores retrovirales que contienen sitios de entrada del ribosoma internos.
ES507394A0 (es) Mejoras en el objeto de la patente de invencion n.487.721 por procedimiento de preparacion de nuevos derivados del nortropano.
YU41493A (sh) Derivati glukagonskog peptida i insulinotropina
ATE125269T1 (de) Radiomarkierte peptide mit antikoagulanswirkung.
ES2064389T3 (es) Composicion de espuma de silicona de baja viscosidad.
ES8504236A1 (es) Procedimiento para preparar derivados del acido oxalico de efectos quimiluminiscentes.
MX9302475A (es) Polipeptido de origen no natural que tiene la actividad del factor recombinante de estimulacion del receptor neu y proceso para la produccion del mis mo.
MX18879A (es) Analogos de la prostaglandina de amida heterociclica substituida con 7-oxabicicloheptilo.
ATE77628T1 (de) Peptidverbindungen.
ES2081817T3 (es) Polipeptido con secuencias principales repetidas que se fijan en la celula.
ES2030709T3 (es) Policarbonatos ramificados conteniendo compuestos de metileno-bis-naftaleno y procedimiento para su fabricacion.
HUT47136A (en) Process for producing cyclic peptides with anticoagulant effect
ES2060078T3 (es) Glicolipido vegetal positivo al ensayo de limulus y metodo de estimular el sistema inmunitario de un animal.
MX171095B (es) Procedimiento para la reduccion de contenido de benceno en las gasolinas
Trube et al. Crustacean cardioactive peptide‐immunoreactive neurons in the ventral nervous system of crayfish
Fine et al. Immunological and Starch-gel Electrophoresis Studies of the Carbonic Anhydrases X 1, X 2 and Y isolated from Human Erythrocyte Hæmolysates
ES2172511T3 (es) Determinacion simultanea de la hba1c y de las variantes de hemoglobina con una glucosilacion analoga a la de la hba1c.
ES2118720T3 (es) Produccion y utilizacion de agentes antihelminticos e inmunogenos protectores.
ES2077674T3 (es) Aumento de la produccion de proteinas en animales.
Chain et al. Improvement of the in vitro T cell proliferation assay by a modified method that separates the antigen recognition and IL-2-dependent steps
ES534980A0 (es) Mejoras en el objeto de la patente principal n 528.903, por: mejoras introducidas en los mecanismos para movimiento de extremidades en los munecos
ATE130194T1 (de) Subkutane verabreichung des humanen choriongonadotropins.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 302429

Country of ref document: ES